• |
  • |
  • |
  • |
Donate

Project

SIDEROS: A Phase III Double-BLind, Randomized, Placebo-controlled Study Assessing the efficacy, safety and...

Center:
Fiscal Year:
2017
Contact Information:
Project Description:
Santhera Pharmaceuticals (Switzerland) SIDEROS: A Phase III Double-BLind, Randomized, Placebo-controlled Study Assessing the efficacy, safety and Tolerability of Idebenone in Patients with DMD Receiving Glucocorticoid Steroids.
Keyword(s):
Core Function(s):
Performing Research or Evaluation
Area of Emphasis
Health-Related Activities
Target Audience:
Children/Adolescents with Disabilities/SHCN
Unserved or Under-served Populations:
Racial or Ethnic Minorities, Disadvantaged Circumstances, Limited English, Geographic Areas
Primary Target Audience Geographic Descriptor:
International
Funding Source:
COVID-19 Related Data:
N/A